SCHEMBL6957503

SCHEMBL6957503

CCOc1nc(C)nc(N2CCc3ccccc3CC2)c1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MGMT P16455 1/20 0.44
HRH4 Q9H3N8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
BLM P54132 1/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 5/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GPR119 Q8TDV5 2/20 0.38
GPR55 Q9Y2T6 1/20 0.38
ALDH1A1 P00352 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953559 0.90 MAPT (0.49) MGMTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL6951003 0.88 MGMT (0.42) MGMTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL6945292 0.88 MGMT (0.45) MGMTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL6953016 0.87 RAB9A (0.39) MGMTHRH4MEN1KMT2ABLM
SCHEMBL6951809 0.87 MEN1 (0.40) MGMTHRH4SMN1; SMN2HTTMEN1
SCHEMBL6948575 0.87 MGMT (0.42) MGMTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL6949472 0.87 MGMT (0.42) MGMTHRH4SMN1; SMN2HTTMEN1
SCHEMBL6947678 0.87 MGMT (0.42) MGMTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL6950115 0.87 MGMT (0.37) MGMTHRH4SMN1; SMN2HTTGPR119
SCHEMBL6948483 0.86 HRH4 (0.41) MGMTHRH4SMN1; SMN2HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed